Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Representative Schwartz Honored as BIO Legislator of the Year

Apr 24 2012
The Biotechnology Industry Organization (BIO) announced today its selection of Representative Allyson Schwartz (D-PA) as Legislator of the Year for 2011-2012.

Senator Hagan Honored as BIO Legislator of the Year

Apr 24 2012
The Biotechnology Industry Organization (BIO) announced today its selection of Senator Kay Hagan (D-NC) as Legislator of the Year for 2011-2012.

Representative Rogers Honored as BIO Legislator of the Year

Apr 24 2012
The Biotechnology Industry Organization (BIO) announced today its selection of Representative Mike Rogers (R-MI) as Legislator of the Year for 2011-2012.

Senator Bob Menendez Honored as BIO Legislator of the Year

Apr 24 2012
The Biotechnology Industry Organization (BIO) announced today its selection of Senator Robert Menendez (D-NJ) as Legislator of the Year for 2011-2012.

Representative Kingston Honored as BIO Legislator of the Year

Apr 24 2012
The Biotechnology Industry Organization (BIO) announced today its selection of Representative Jack Kingston (R-GA) as Legislator of the Year for 2011-2012.

Coca Cola and Dow Chemical Among Companies to Bring Consumer Focus to 2012 World Congress on Industrial Biotechnology

Apr 19 2012
Representatives from the Dow Chemical Company, Coca Cola, the National Defense Center for Energy and Environment and more will discuss the innovative use of industrial biotech in consumer products. 

BIO Announces Governor Jon Huntsman as Keynote Speaker for the BIO Convention in China

Apr 19 2012
BIO China event will be held October 24-25 in Shanghai

Biotechnology Patenting and Intellectual Property to be Highlighted at 2012 BIO International Convention

Apr 18 2012
This global event for biotechnology will be held June 18-21, 2012 in Boston.

Leaders in Science, Advocacy to Judge 2012 Biotech Humanitarian Award

Apr 18 2012
Nominations for the award close on April 20.

BIO Submits Comments on FDA Draft Guidances on Biosimilars

Apr 17 2012
The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food and Drug Administration (FDA) on three draft guidance documents on biosimilar products.